Sep 16, 2026 08:05AM
Sep 16, 2026 08:05AM
Sep 1, 2026 08:06AM
Sep 1, 2026 08:05AM
Aug 6, 2026 08:05AM
Aug 6, 2026 08:05AM
Jul 21, 2026 08:05AM VivoSim makes first commercial sales in China for NAMkind testing
Jul 21, 2026 08:05AM
Jul 16, 2026 08:30AM
Jul 16, 2026 08:30AM
Jul 15, 2026 10:42AM
Jul 15, 2026 08:05AM
Jul 15, 2026 08:05AM
Jun 29, 2026 08:05AM VivoSim presents liver toxicity data at European toxicology conference
Jun 29, 2026 08:05AM
Apr 28, 2026 08:05AM
Apr 28, 2026 08:05AM
Apr 1, 2026 08:05AM
Apr 1, 2026 08:05AM
Apr 1, 2026 08:05AM
Apr 1, 2026 08:05AM VivoSim Announces Pricing of up to a $4 Million Public Offering
Mar 24, 2026 08:05AM
Mar 24, 2026 08:05AM
Mar 3, 2026 08:05AM
Mar 3, 2026 08:05AM
Feb 11, 2026 08:05AM
Feb 11, 2026 08:05AM
Jan 29, 2026 04:05PM VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
Jan 6, 2026 08:06AM
Jan 6, 2026 08:05AM
Aug 14, 2025 08:05AM
Aug 14, 2025 08:05AM
May 13, 2025 08:05AM
May 7, 2025 08:05AM
Apr 24, 2025 08:05AM VivoSim Labs (VIVS) Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
Apr 24, 2025 08:05AM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All